This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ragaz J et al. (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97: 116–126
Overgaard M et al. (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949–955
Overgaard M et al. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641–1648
Nielsen HM et al. (2004) The course and prognosis for loco-regional recurrences among high-risk breast cancer patients receiving adjuvant systemic treatment and randomized to +/− postmastectomy radiotherapy. Long-term results from the Danish DBCG 82b&c studies with 3083 patients [abstract #320]. Eur J Cancer Suppl 2: 148
Overgaard M et al. (2004) Is the benefit of postmastectomy irradiation limited to patients with 4 or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b & c randomized trials [abstract #33]. Radiother Oncol 73 (Suppl 1): S14–S15
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kochanski, J., Chmura, S. Is postmastectomy radiotherapy useful in elderly women with high-risk breast cancer?. Nat Rev Clin Oncol 3, 422–423 (2006). https://doi.org/10.1038/ncponc0567
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0567